Medical nutrition refers to a group of medical food products taken under the supervision of health practitioners for the nutritional management of a condition or disease.
The global medical nutrition market is expected to register significant growth in the forecoming years. Major factors driving growth of the global medical nutrition markets are, changing eating habit of consumers coupled with increasing demand for healthy food across the globe. In addition, instances of chronic and lifestyle diseases, changing life style, rising purchasing power are the factors boosting the demand for medical nutrition.
The global medical nutrition market report has been segmented on the basis of product, indication, and region.
On the basis of product, the global medical nutrition market has been segmented into infant nutrition, parenteral nutrition, and enteral nutrition.
On the basis of indications, the global medical nutrition market has been segmented into hepatic disorders, renal disorders, diabetes, dysphagia, oncology nutrition, neurology nutrition, and others.
On the basis of region, the global medical nutrition markets segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Request for the Sample Report Here: https://marketresearch.biz/report/medical-nutrition-market/request-sample/
In 2018, North America medical nutrition market is expected to account for major share in the global market in terms of revenue, and is expected to maintain its dominance over the forecast period. This is primarily attributed, due increasing incidence of chronic diseases and disorder in country in the region. However, Asia Pacific medical nutrition market is projected to register highest CAGR in the next five years, due to demand for better quality therapy and healthcare facilities in the region.
Key players operating in the global medical nutrition market include NUTRICIÓN MÉDICA SL, Meiji Holdings Co., Ltd., Medtrition Inc., Baxter International Inc., B. Braun Melsungen AG., Fresenius Kabi AG, Mead Johnson & Company, LLC, Otsuka Holdings Co., Ltd., Victus, Inc., and Cambrooke Therapeutics, Inc.